Back to Business

PolyPeptide Studies Strategic Options as Private Equity Circles

Business April 14, 2026 at 6:43 AM

PolyPeptide Studies Strategic Options as Private Equity Circles

Bloomberg Markets

PolyPeptide Group AG and its billionaire shareholder Frederik Paulsen are working on strategic options for the company.

Read at Bloomberg Markets

More Stories

Mondelez: Durable Snacking With Volume And Price Tailwinds Entering FY2026 - Reiterate Buy

🇺🇸 Seeking Alpha 20m ago

Zoom: Potential Value Trap With Single-Digit Growth Profile - Maintain Hold

🇺🇸 Seeking Alpha 20m ago

UnitedHealth: Solid Annual Total Return Potential Makes It A Buy

🇺🇸 Seeking Alpha 23m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play